For instance, Xu et al. reported that hepatic GSDMD-N protein levels were significantly higher in humans suffering from NASH and correlated with the NAFLD activity score and fibrosis and that GSDMD KO mice fed a MCD exhibited decreased severity of steatosis and inflammation compared with WT littermates [12]. Here, GSDMD is linked to metabolic dysfunction-associated steatotic liver disease.